These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34143301)

  • 41. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial.
    Hill NR; Lasserson D; Thompson B; Perera-Salazar R; Wolstenholme J; Bower P; Blakeman T; Fitzmaurice D; Little P; Feder G; Qureshi N; Taal M; Townend J; Ferro C; McManus R; Hobbs FR
    Trials; 2014 May; 15():160. PubMed ID: 24886488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antioxidants for chronic kidney disease.
    Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.
    Matsushita K; Ballew SH; Wang AY; Kalyesubula R; Schaeffner E; Agarwal R
    Nat Rev Nephrol; 2022 Nov; 18(11):696-707. PubMed ID: 36104509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE).
    Yuan J; Zou XR; Han SP; Cheng H; Wang L; Wang JW; Zhang LX; Zhao MH; Wang XQ;
    BMC Nephrol; 2017 Jan; 18(1):23. PubMed ID: 28088175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality.
    Voicehovska JG; Bormane E; Grigane A; Moisejevs G; Moreino E; Trumpika D; Voicehovskis VV
    Heart Lung Circ; 2021 Nov; 30(11):1694-1701. PubMed ID: 34503918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring cardiovascular risk factors in children on dialysis.
    Shroff R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S173-5. PubMed ID: 19270210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of quality of sleep between patients with chronic kidney disease not on hemodialysis and end-stage renal disease on hemodialysis in a developing country.
    Shafi ST; Shafi T
    Ren Fail; 2017 Nov; 39(1):623-628. PubMed ID: 28805481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives.
    Evans M; Lewis RD; Morgan AR; Whyte MB; Hanif W; Bain SC; Davies S; Dashora U; Yousef Z; Patel DC; Strain WD
    Adv Ther; 2022 Jan; 39(1):33-43. PubMed ID: 34739697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study.
    Ezeanuna MN; Prince DK; Alexander SA; Richards JS; Kerr GS; Jalal D; Bansal N; Liew JW; Singh N
    Clin Rheumatol; 2022 Sep; 41(9):2669-2676. PubMed ID: 35610408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.
    Grabner A; Mazzaferro S; Cianciolo G; Krick S; Capelli I; Rotondi S; Ronco C; La Manna G; Faul C
    Contrib Nephrol; 2017; 190():83-95. PubMed ID: 28535521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic kidney disease emerging trends in children and what to do about it.
    Beng-Ongey H; Robinson JS; Moxey-Mims M
    J Natl Med Assoc; 2022 Jun; 114(3S2):S50-S55. PubMed ID: 35660045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
    Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
    BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient and caregiver perspectives on blood pressure in children with chronic kidney disease.
    Wu JG; Tong A; Evangelidis N; Manera KE; Hanson CS; Baumgart A; Amir N; Sinha A; Dart A; Eddy AA; Guha C; Gipson DS; Bockenhauer D; Yap HK; Groothoff J; Zappitelli M; Alexander SI; Furth SL; Samuel S; Carter SA; Walker A; Kausman J; Martinez-Martin D; Gutman T; Craig JC
    Nephrol Dial Transplant; 2022 Jun; 37(7):1330-1339. PubMed ID: 34086937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1-4 patients.
    Yuan Q; Xie Y; Peng Z; Wang J; Zhou Q; Xiao X; Wang W; Huang L; Tang W; Li X; Zhang L; Wang F; Zhao MH; Tao L; He K; Wanggou S; Xu H;
    Clin Nutr; 2021 Apr; 40(4):2394-2400. PubMed ID: 33160701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Palliative and end-of-life care issues in chronic kidney disease.
    Combs SA; Davison SN
    Curr Opin Support Palliat Care; 2015 Mar; 9(1):14-9. PubMed ID: 25581447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.